Patient’s Name: JOSIE BAROTILLO VELASCO
Medical Diagnosis: PU 32 2/7 weeks AOG twin gestation cephalic, breech in threatened pre-term labor
(ASPIRIN/ ACETYLSALICYLIC ACID/ ASA)
Indication: prevention of pre-eclampsia
Indications for Use:
Analgesia
Treatment of fever; anti-pyretic
Anti-inflammation
Reduces inflammation related to rheumatoid
arthritis (RA), juvenile arthritis, osteoarthritis,
rheumatic fever
Used as platelet aggregation inhibitor in the
prevention of transient ischemic attacks, (TIAs),
cerebral thromboembolism, MI or reinfarction.
Adjunctive treatment of Kawasaki’s disease.
Contraindications:
Hypersensitivity to salicylates, NSAIDS
Asthma, rhinitis, nasal polyps
Inherited or acquired bleeding disorders
Use in children (younger than
16 yrs) for viral infections.
References:
Classification: PHARMACOTHERAPEUTIC- Nonsteroidal salicylate
NURSING RESPONSIBILITIES:
(This should include all warnings, specific instructions on preparation, mixing, administration, monitoring, etc. You may list all,
and then tick the boxes applicable for your patient. Include IV and oral preparations.)
Preparation:
Do not give to children or
teenagers who have or recently had
viral infections (increases
risk of Reye’s syndrome)
Do not use if vinegar-like odor is
noted (indicates chemical
breakdown)
Assess type, location, duration
of pain, inflammation.
Inspect appearance of affected
joints for immobility, deformities,
skin condition.
Do not break, crush, dissolve, or
divide enteric-coated tablets.
Chewable tablets may be
chewed, dissolved in liquid, or
swallowed whole.
Some extended-release tablets
may be broken or crumbled but
must not be ground up before
swallowing. See manufacturer’s
prescribing information for individual
products.
Age/Sex: 28 y/o, Female Ward/Bed No: W15B07
Date of Assignment: September 27, 2016
(80 mg/PO/OD)
Administration:
Administer after meals or with
food or an antacid to minimize
gastric irritation. Food slows but
does not alter the total amount
absorbed.
Monitoring
Assess skin for evidence of
ecchymosis.
Monitor urinary pH (sudden
acidification, pH from 6.5 to 5.5, may
result in toxicity).
If given as anti-pyretic, assess
temperature directly before and 1 hr
after giving medication.
Report tinnitus or persistent
abdominal GI pain, bleeding.
Evaluate for therapeutic
response: relief of pain, stiffness,
swelling; increased joint mobility;
reduced joint tenderness; improved
grip strength.
Patient’s Name: JOSIE BAROTILLO VELASCO Age/Sex: 28 y/o, Female Ward/Bed No: W15B07
Medical Diagnosis: PU 32 2/7 weeks AOG twin gestation cephalic, breech in threatened pre-term labor Date of Assignment: September 27, 2016

(CALCIUM CARBONATE) (1 tab/PO/BID)

Indication:treatment, prevention of calcium deficiency Classification: Therapeutic- mineral and electrolyte replacements/ supplements
Indications for Use: NURSING RESPONSIBILITIES:
Antacid (This should include all warnings, specific instructions on preparation, mixing, administration, monitoring, etc. You may list all,
Treatment/prevention of calcium deficiency and then tick the boxes applicable for your patient. Include IV and oral preparations.)
Treatment/prevention of hyperphosphatemia.
Preparation: Administration: Monitoring

Do not confuse Os-Cal (calcium Administer calcium carbonate or
carbonate) with Asacol phosphate 1–1.5 hr after meals and
(mesalamine). at bedtime.
Dissolve effervescent tablets in Follow oral doses with a full
glass of water. glass of water, except when using
calcium carbonate as a phosphate
. binder in renal dialysis.
Administer on an empty
stomach before meals to optimize
effectiveness in patients with
Contraindications: hyperphosphatemia.
Hypercalcemia; Remind client to thoroughly
Renal calculi chew chewable tablets before
Ventricular fibrillation; swallowing.
Concurrent use of calcium supplements (calcium
acetate)
Monitor serum BMP, calcium,
ionized calcium, magnesium,
phosphate
Monitor B/P, cardiac rhythm,
renal function.
Monitor for signs of
hypercalcemia.
Advise patient that calcium
carbonate may cause constipation.
Review methods of preventing
constipation (increasing bulk in diet,
increasing fluid intake, increasing
mobility) and using laxatives.
Severe constipation may indicate
toxicity.

References:
Patient’s Name: JOSIE BAROTILLO VELASCO Age/Sex: 28 y/o, Female Ward/Bed No: W15B07
Medical Diagnosis: PU 32 2/7 weeks AOG twin gestation cephalic, breech in threatened pre-term labor Date of Assignment: September 27, 2016

(FERROUS SULFATE) (1 tab/PO/OD)

Indication:prevention/treatment of iron-deficiency anemia Classification: Pharmacologic- iron supplements
Indications for Use: NURSING RESPONSIBILITIES:
Prevention, treatment of iron deficiency anemia due (This should include all warnings, specific instructions on preparation, mixing, administration, monitoring, etc. You may list all,
to inadequate diet, malabsorption, pregnancy, blood loss. and then tick the boxes applicable for your patient. Include IV and oral preparations.)
Dietary supplement for iron
Preparation: Administration: Monitoring

Store all forms (tablets, Discontinue oral iron
capsules, suspension,drops) at preparations prior to parenteral
room temperature. administration.
Do not crush or chew Oral preparations are most
enteric-coated tablets and do not effectively absorbed if administered
open capsules. 1 hr before or 2 hr after meals.
If gastric irritation occurs,
administer with meals.
Take tablets and capsules with a
full glass of water or juice.
Contraindications: Liquid preparations may stain
Hemochromatosis, hemosiderosis, or other teeth. Dilute in water or fruit juice,
evidence of iron overload; full glass (240 mL) for adults and 1/2
Anemias not due to iron deficiency; glass (120 mL) for children, and
Some products contain alcohol, tartrazine, or administer with a straw or place
sulfites and should be avoided in patients with drops at back of throat.
known intolerance or hypersensitivity.
Monitor serum iron, total
iron-binding capacity, reticulocyte
count, Hgb, ferritin.
Monitor daily pattern of bowel
activity stool consistency.
Assess for clinical
improvement,record relief of iron
deficiency symptoms (fatigue,
irritability, pallor, paresthesia of
extremities, headache).
Advise patient that stools may
become dark green or black and
that this change is harmless.

References:
Patient’s Name: JOSIE BAROTILLO VELASCO
Medical Diagnosis: PU 32 2/7 weeks AOG twin gestation cephalic, breech in threatened pre-term labor
(MULTIVITAMIN) (1 tab/PO/OD)
Indication: treatment, prevention of vitamin deficiencies Classification: multivitamin
Indications for Use: NURSING RESPONSIBILITIES:
Dietary supplement for the treatment and prevention (This should include all warnings, specific instructions on preparation, mixing, administration, monitoring, etc. You may list all,
of vitamin deficiencies. and then tick the boxes applicable for your patient. Include IV and oral preparations.)
Preparation:
For IV preparations: Dilute the
contents of Vial 1 (5mL) and the
contents of Vial 2 (5mL) in not less
than 500 mL infusion fluid, both vials
to be used for a single dose. The
Vial 1 and Vial 2 container closures
may be penetrated only one time,
utilizing a suitable sterile transfer
device or dispensing set, which
allows measured distribution of the
Contraindications: contents.
Known alcohol intolerance
Hypersensitivity to preservatives, colorants, The withdrawal of container
additives, including tartrazine, saccharin, aspartame contents should be accomplished
(oral forms) without delay. The solution should
be administered within 4 hours after
dilution.
References:
Age/Sex: 28 y/o, Female Ward/Bed No: W15B07
Date of Assignment: September 27, 2016
Administration:
For PO: Do not take more than
the recommended dosage. If you
are uncertain about any of the
information, consult your doctor or
pharmacist.
Monitoring
For IV: Clinical status and
vitamin levels should be
monitored in patients receiving
parenteral multivitamins as the
only source of vitamins for
extended periods of time. It is
particulary important to monitor
for adequate supplementation of,
for example:
• Vitamin A in patients with pressure
ulcers, wounds, burns, short bowel
syndrome or cystic fibrosis
• Vitamin B1 in dialysis patients
• Vitamin B2 in cancer patients
• Vitamin B6 in patients with renal
impairment and Individual vitamins
whose requirements may be
increased due to interactions with
other medicines (See Interactions
with other medicines)
Patient’s Name: JOSIE BAROTILLO VELASCO Age/Sex: 28 y/o, Female Ward/Bed No: W15B07
Medical Diagnosis: PU 32 2/7 weeks AOG twin gestation cephalic, breech in threatened pre-term labor Date of Assignment: September 27, 2016

(MICRONIZED PROGESTERONE) (200 mg/tab/ODHS per vagina)

(PROMETRIUM)
Indication: Secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance Classification: Therapeutic- hormones
Indications for Use: NURSING RESPONSIBILITIES:
Secondary amenorrhea and abnormal uterine (This should include all warnings, specific instructions on preparation, mixing, administration, monitoring, etc. You may list all,
bleeding due to hormonal imbalance. and then tick the boxes applicable for your patient. Include IV and oral preparations.)
Prevention of cell overgrowth in the uterine lining in
postmenopausal women who have not had a Preparation: Administration: Monitoring
hysterectomy (with estrogen).
Part of assisted reproductive technology (ART) in the Vaginal Gel: Remove applicator PO: If given in morning, BP be monitored periodically
management of infertility (4% and 8% vaginal gel) from sealed wrapper. Do not administer 2 hrs after breakfast with during therapy.
. remove twist-off tab at this time. full glass of water. Monitor intake and output ratios
Hold applicator by thick end. Vaginal: Hold applicator by flat and weekly weight. Report
Shake down several times (like a section of thick end and twist off tab significant discrepancies or steady
thermometer) to ensure contents at other end. Do not squeeze thick weight gain.
are at thin end. end while twisting tab (could force Advise patient to report signs
some gel to be released before and symptoms of fluid retention
insertion). (swelling of ankles and feet, weight
Insert applicator into vagina gain), thromboembolic disorders
Contraindications: either in sitting position or lying on (pain, swelling, tenderness in
Hypersensitivity; back with knees bent. extremities, headache, chest pain,
Hypersensitivity o parabens or sesame oil (IM Insert thin end well into vagina. blurred vision), mental depression,
suspension only); Squeeze thick end of applicator to or hepatic dysfunction (yellowed
Hypersensitivity to peanuts (Prometrium only); deposit gel skin or eyes, pruritus, dark urine,
Thromboembolic disease; Remove applicator, discard. lightcolored stools) to health care
Cerebrovascular disease; professional.
Severe liver disease; .
Breast or genital cancer; Porphyria;
Missed abortion;
OB: Contraindicated except in
corpus luteum dysfunction.

References: